Prediction: This Will Be Micron's Stock Price by Late 2027 (Hint: It Implies a Big Move)

Micron reported revenue up 345% YoY in Q3 FY2026 (ended May) as DRAM/NAND prices more than doubled, and guided Q4 revenue up ~340% with non-GAAP adjusted net income up >900%. The article projects Micron sales could reach ~$250B in fiscal 2027, but warns valuation may contract as investors look past the current memory supply shortage. It also frames the stock’s upside case with a target of ~$1,875 per share (~91% upside from ~$982) assuming a P/S multiple compresses to 8.5x by late 2027.

Analysis

The near-term winner is still MU, but the more important market mechanism is that scarcity is now a negotiating tool, not a permanent moat. When memory gets this tight, the first beneficiaries are the suppliers with the best HBM allocation and the cleanest contract book; the second-order winner is the broader AI stack if constrained memory forces hyperscalers to pre-buy more inventory and prioritize fewer accelerator vendors. That is supportive for NVDA in the sense of supply discipline, but it also raises the cost of deployed AI capacity and can pressure the pace of rollout at the margin.

The bigger issue is timing: the stock market usually discounts the down-cycle 2-4 quarters before it shows up in reported numbers. If capex from MU, SKHYV, and peers accelerates into 2027, the market will likely start compressing the multiple on any sign that spot pricing has stopped inflecting higher, even if earnings are still booming. In other words, the risk is not a bad quarter; it is the first credible evidence that 2028 supply is already being pulled forward.

Contrarian view: consensus is treating the current shortage as a longer-duration supercycle, but the more likely outcome is a classic cycle with a delayed peak and a very fast rerating once growth normalizes. The thesis is falsified if HBM/DRAM pricing stays elevated through 2H27 and customer contracts continue to reprice upward without volume concessions; it breaks if memory capex guidance tightens or if lead times fail to normalize despite new capacity plans. Near term, this is more a trade-on-volatility name than a set-and-forget compounder.

Key Decisions for Investors

• Do not chase MU at current levels; prefer a 10-15% pullback entry or structure exposure with 6-12 month call spreads to cap valuation-compression risk.
• Relative-value: long SKHYV / short SNDK for 6-12 months. HBM scarcity should remain structurally tighter than NAND, while NAND is the more obvious oversupply candidate once the cycle turns.
• If already long MU, hedge with a small SMH or SOXX short against the position into earnings; the beta trade is cleaner than trying to time the peak on the single name.
• Set a monitor for any sign of 2027 capex acceleration or pricing plateau in memory contracts; if that appears, rotate out of cyclicals into a later-cycle beneficiary basket immediately.
• For opportunistic traders, sell downside puts on MU only on a sharp 8-12% drawdown; the risk/reward is better when implied vol spikes than after a 700% run.